Live Breaking News & Updates on Pharma entrepreneurs

Stay informed with the latest breaking news from Pharma entrepreneurs on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharma entrepreneurs and stay connected to the pulse of your community

How is India streamlining the pharma sector? | Explained

How is India streamlining the pharma sector? | Explained
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Gambia , India , United-kingdom , Republic-of-the-gambia , British , Harishk-jain , Rajeev-singh-raghuvanshi , Raheel-shah , Department-of-pharmaceuticals , Union-list , Federation-of-pharma-entrepreneurs , Central-drugs-standard-control-organisation

drug reforms panel: Govt expands committee for drug and medical device pricing reforms, includes more industry representation

The government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This move aims to ensure better availability of medicines and devices, while also providing incentives for industry growth and export sustainability. The committee will engage with industry experts and associations to evaluate pricing and availability issues. Ultimately, the government will make the final decisions, with the committee focusing on balancing pricing and availability of essential medicines and designing a price moderation framework for medical devices.

India , Organisation-of-pharmaceutical-producers-india , Us-india-strategic-partnership-forum , Technology-association-of-india-mtal , Federation-of-pharma-entrepreneurs , Association-of-indian-medical-device-industry , Confederation-of-indian-industry , National-pharmaceutical-pricing-authority , Pharmaceutical-producers , India-strategic-partnership-forum , Medical-technology-association

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Lupin-ltd , Federation-of-pharma-entrepreneurs , Cipla-ltd , Sun-pharmaceuticals , National-pharmaceutical-pricing-authority , Alkem-laboratories , Mankind-pharma , Torrent-pharma , Drug-price-control-order , Pharma-entrepreneurs , India

FOPE urges pause on NPPA notice, citing potential losses for pharma industry

FOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the price expeditiously and as per the NPPA's defined timelines for various provisions under DPCO including disposal of Form-1 application.

India , National-pharmaceuticals-pricing-authority , Federation-of-pharma-entrepreneurs , Pharma-entrepreneurs , Pharma-industry , Fope , Nppa-notice , Drug-pricing-regulator , Retail-prices , Dpco ,

PLI scheme: Pharma industry expects more guidelines on investment


The pharma industry felt the PLI scheme leads the way to create more global-scale pharma companies in India. The industry expects more guidelines to come out on minimum investment criterion to qualify for the scheme. If the Centre only links the incentive to incremental sales value, the industry is happy, said an industry insider.
Ramesh Swaminathan, chief financial officer and head of corporate affairs at Lupin, said, they are eagerly awaiting the finer details of the scheme. Meanwhile, B R Sikri, chairman of the Federation of Pharma Entrepreneurs, said, higher incentives would have meant more production of cancer drugs, thereby, bringing down their prices.

Sikri , Uttar-pradesh , India , Sudarshan-jain , Ramesh-swaminathan , Indian-pharmaceutical-alliance , Federation-of-pharma-entrepreneurs , Pharma-entrepreneurs , Pli-scheme , Pharma-industry , Investment , Cancer

Making Medicines in India- Business News


Making Medicines in India
Centre has announced two schemes to reduce import dependence in medicine manufacturing. Will they work this time?
Illustration by Raj Verma
The Department of Pharmaceuticals had gone into a huddle as early as February this year when India had only three confirmed cases of Covid-19. A committee of inter-ministerial experts and importers and manufacturers of medicines met every day to keep a watch on happenings in China. Their worry was not just the spread of the disease. They were also concerned about the lockdown in China and its impact on supply of key raw materials used to make medicines in India.

Sikri , Uttar-pradesh , India , Hyderabad , Andhra-pradesh , Karnataka , Tamil-nadu , China , Hubei , Guangdong , Telangana , Haryana